Ebola | ||||||
NEWS | ||||||
Recombinant Vaccines Market Is Expanding At A CAGR Of 6.4% From 2017 To 2025 – Credence ... Expected launch of recombinant vaccines such as VPM1002 (BCG), EBOV-GP (ebola), Shingrix (herpes zoster), GSK-2189242A (pneumococcal ...
| ||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar